Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1

Interventions

Specimen Handling 7Biopsy 7Magnetic Resonance Spectroscopy 6duvelisib 3X-Rays 3sodium-iodide symporter 2cemiplimab 2Photons 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Immunoglobulin G 2Etoposide 2Disulfides 2Cyclophosphamide 2Azacitidine 210-propargyl-10-deazaaminopterin 2tazemetostat 1talimogene laherparepvec 1ruxolitinib 1pembrolizumab 1carmustine, poliferprosan 20 drug combination 1belinostat 1Whole-Body Irradiation 1Vincristine 1Stem Cell Transplantation 1Standard of Care 1Spinal Puncture 1Prednisone 1Practice Guidelines as Topic 1Pharmacogenomic Variants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × carmustine, poliferprosan 20 drug combination × 30 days × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡